MyrLiq® (Commiphora myrrha Oleo-Gum Resin Extract) Manufacturer & Supplier in India | MEDIOCON INC

MyrLiq® – Commiphora myrrha Oleo-Gum Resin Extract

MEDIOCON INC offers MyrLiq®, a standardized botanical extract derived from the gum-resin of Commiphora myrrha, commonly known as myrrh.

MyrLiq® is characterized by a high concentration of naturally occurring furanodienes, including curzerene, furanoeudesma-1,3-diene and lindestrene. Published research describes MyrLiq® as a Commiphora myrrha extract produced from myrrh gum-resin and standardized for these bioactive constituents.

The ingredient is available as both powder and liquid extract forms, according to the product information from Biosfered, and is positioned for nutraceutical and specialty botanical applications.

Product Overview

MyrLiq® is produced from the oleo-gum-resin of Commiphora myrrha, a thorny tree belonging to the Burseraceae family.

The extract is distinguished by its high furanodiene content. Published analytical data reported approximately 12.31 g/kg curzerene, 18.84 g/kg furanoeudesma-1,3-diene and 6.23 g/kg lindestrene, with total furanodienes of approximately 40.86 g/kg in the tested MyrLiq® material.

MyrLiq® has been investigated in preclinical and human research for its biological properties, including research into pain-related applications. These research findings should not be interpreted as a medical treatment claim for the commercial ingredient.

Botanical Source

Botanical Name: Commiphora myrrha (Nees) Engl.

Common Name: Myrrh

Family: Burseraceae

Raw Material: Myrrh gum-resin / oleo-gum-resin

The gum-resin is obtained from the trunk of Commiphora myrrha.

Key Active / Marker Constituents

• Curzerene
• Furanoeudesma-1,3-diene
• Lindestrene
• Total furanodienes

The published MyrLiq® analytical profile identifies these three compounds as principal standardized constituents and reports a high total furanodiene content.

Key Features

• Branded botanical ingredient
• Derived from Commiphora myrrha gum-resin
• High-furanodiene botanical extract
• Standardized marker compounds
• Contains naturally occurring sesquiterpenes
• Available in powder and liquid forms
• Suitable for nutraceutical applications
• Suitable for botanical formulations
• Suitable for specialty dietary supplement formulations
• Natural plant-derived ingredient

Applications

MyrLiq® may be considered for:

• Nutraceutical formulations
• Botanical supplements
• Dietary supplement formulations
• Herbal formulations
• Specialty wellness products
• Botanical ingredient blends
• Research formulations
• Functional botanical products

The commercial positioning and permitted claims should always follow the applicable regulatory requirements in the target market.

Furanodiene Standardization

MyrLiq® is particularly differentiated by its furanodiene profile.

Published analytical work reported:

• Curzerene: approximately 12.31 g/kg
• Furanoeudesma-1,3-diene: approximately 18.84 g/kg
• Lindestrene: approximately 6.23 g/kg
• Total furanodienes: approximately 40.86 g/kg

These values are reported from the studied MyrLiq® material and should not automatically be treated as the contractual specification for every commercial batch; the current supplier CoA should be used for batch-specific specifications.

Research Background

MyrLiq® has been investigated in a randomized, double-blind, placebo-controlled pilot study involving adults with different pain-related conditions. The study evaluated MyrLiq® at two intake levels over a 20-day period and reported pain-related outcomes.

The research provides scientific background for the ingredient but should not be used to make unapproved therapeutic or disease-treatment claims on a commercial product page.

Quality & Documentation

MEDIOCON INC can support commercial sourcing requirements with available technical and quality documentation, subject to supplier availability.

Typical documentation may include:

• Certificate of Analysis (CoA)
• Product Specification
• Technical Data Sheet
• Safety Data Sheet (SDS)
• Botanical identification
• Marker-compound specification
• Furanodiene assay
• Microbiological analysis
• Heavy-metal analysis
• Pesticide-residue documentation
• Allergen Statement
• GMO Statement
• Regulatory documentation
• Batch documentation

Storage

Store in a cool, dry place in tightly closed original packaging.

Protect from:

• Moisture
• Excessive heat
• Direct sunlight
• Contamination

Exact storage conditions should be confirmed from the current MyrLiq® technical specification and CoA.

Packaging

MyrLiq® is reported in both powder and liquid extract forms. Packaging should be confirmed according to the selected form, commercial quantity and customer requirements.

Product Forms

Powder Extract

Yellowish botanical powder produced from Commiphora myrrha gum-resin.

Liquid Extract

Fluid Commiphora myrrha gum-resin extract with high furanodiene content.

Important Product Classification

MyrLiq® is a standardized botanical extract, not a single chemical compound.

Therefore, the complete branded ingredient does not have one unique molecular formula or molecular weight.

For CAS purposes, 84929-26-0 is reported for Commiphora myrrha resin extract in cosmetic ingredient databases, but this should not be represented as a unique CAS number specifically assigned to the MyrLiq® branded standardized extract.

Why Choose MyrLiq®?

MyrLiq® provides a differentiated Commiphora myrrha botanical extract with a defined furanodiene profile. Its standardization around curzerene, furanoeudesma-1,3-diene and lindestrene makes it suitable for specialized botanical and nutraceutical formulation development.

MEDIOCON INC supports customers seeking specialized botanical extracts with appropriate technical, quality and regulatory documentation.